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Abstract
Background: Duchenne muscular dystrophy (DMD) is characterized by muscle damage and progressive loss of
muscle function in male children. DMD is one of the most devastating genetically linked neuromuscular diseases for
which there is currently no cure. Most clinical studies for DMD utilize a standard protocol for measurement
exploring pathophysiology, muscle strength and timed tasks. However, we propose that examining broader
components of health as emphasized by the International Classification of Functioning, Disability and Health-
Children and Youth Version (ICF-CY) may be of great value to children and their families, and important outcomes
for future clinical trials.
Methods: Fifty boys with DMD and 25 unaffected age-matched boys completed two self-report measures: the
Children’s Assessment of Participation and Enjoyment and the Pediatric Quality of Life Inventory
TM 4.0. We
investigated differences between the two groups with regard to participation in life activities and perceived quality
of life (QoL). Additionally, we compared participation in activities and QoL in both cohorts of younger and older
boys.
Results: Participation in physical activities was significantly lower in boys with DMD than unaffected boys. Perceived
QoL was markedly diminished in children with DMD relative to unaffected controls, except in the emotional
domain. The amount of time boys engage in an activity, as well as participation in social activities, declined for our
older boys with DMD but no changes were observed for our older unaffected boys. For both groups, QoL remained
constant over time.
Conclusions: The ICF-CY provides a conceptual framework and specific terminology that facilitates investigation of
the consequences of impairment in children and youth. Our study is one of the first to explore participation in a
cohort of boys with DMD. It was not surprising that activities of choice for boys with DMD were less physical in
nature than unaffected boys their age, but the consequences of less social engagement as the boys with DMD age
is of great concern. Results from our study underscore the need to further evaluate activities that children elect to
participate in, with special emphasis on facilitators and barriers to participation and how participation changes
throughout the course of a disease.
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Duchenne muscular dystrophy (DMD), the most common
form of muscular dystrophy, is a genetically-linked disease
of male children which affects one in 3,300 boys [1]. The
muscle damage and weakness which occurs with this
disease leads to a progressive decline in the boy’sa b i l i t y
to perform everyday tasks, such as climbing stairs and
walking short distances [2-4]. Disruption to the lives of
children with DMD and their families begins as early as
age three when muscle weakness interferes with daily
activities. As the weakness progresses, the boys often be-
come confined to wheelchairs early in the second decade
of life [5]. End stage cardiac and respiratory complica-
tions lead to death which frequently occurs around the
age of 20 [6-8]. Overall, DMD leads to a loss of func-
tional independence and deterioration in the quality of
life for both the children and their families [9-13].
It is imperative to develop techniques which can be
used to follow the progression of this disease as well as
the efficacy of any therapeutic interventions. Traditional
measures used to follow DMD are typically clinical mea-
sures of skeletal muscle structure and function [14-17].
These outcome measures include muscle strength, man-
ual muscle testing, range of motion, forced vital capacity,
anthropometric tests, timed functional tests and the 6
min walk. In addition, there are also invasive techniques,
such as muscle biopsy, and noninvasive techniques, such
as magnetic resonance imaging, which have been used to
follow the structural and compositional changes that
occur with the progression of DMD [18,19]. Although
these measures represent the current models on which
clinical progression of the disease is based [20,21], such
measurements may not fully capture the impact of the
disease on real life activities. The medical community
has long assumed that disability directly correlates with
the measurements made in a clinical setting. However, it
has been shown that measures of pathophysiology and
motor function assessed in the clinic do not necessarily
relate to or predict how patients deal with life situations
[22-24]. Clinical measures are often disconnected from
the context and synergy of everyday life. Therefore, per-
haps other nontraditional outcome measures would also
be valuable in following the progression of DMD.
One outcome measure which could be used to
evaluate the ability of boys with DMD to manage real
life situations is to determine their degree of partici-
pation in various activities. The International Classifi-
cation of Functioning, Disability, and Health-Children
and Youth Version (ICF-CY) adopted by the World
Health Organization (WHO) [25] (Figure 1) identifies
participation as an important outcome of health. Par-
ticipation is defined as direct engagement in a life
situation including activities of personal care, mobility,
social relationships, education, recreation and leisure,
spirituality, and community life [25,26]. It has been
reported that children with physical disabilities engage
in less varied activities than healthy children [27-30].
To the best of our knowledge, participation levels
among children with DMD and changes in the pat-
terns of participation with age and disease progression
have not been investigated. Therefore, there is a need
to quantify participation in boys with DMD and the
effect participation may have on their quality of life
throughout the course of the disease.
Quality of life (QoL) measures have often been used in
the healthcare field to compare diseases, determine the
effects of an illness [31], and measure the outcomes of
treatments and clinical trials [32,33]. It is possible that QoL
measures can shed new insight into patient outcomes that
traditional physical measures may not be able to assess
[11,33-35]. It has been reported that children with chronic
illnesses typically score below healthy children in QoL
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Figure 1 International Classification of Functioning, Disability and Health-Children and Youth Version (ICF-CY).
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such as DMD have been excluded from most comparative
studies [36,37]. Surprisingly, there is little information on
the QoL of children with DMD despite parents reporting
quality of life issues as an important challenge for their
children [38,39]. The progressive decline in strength and
loss of the ability to participate in activities with their peers
can lead to social exclusion and isolation for these boys.
These factors may have a significant impact on how boys
with DMD perceive their quality of life.
The objectives of this investigation were 1) to compare
boys with DMD with an unaffected age-matched popula-
tion of boys with regard to participation in real life activities
and perceived quality of life, 2) to determine the differences
in participation in activities and perceived quality of life in
younger and older boys with DMD and unaffected boys to
explore the effects of disease progression, and 3) to deter-
mine if there is a relationship between participation in ac-
tivities and perceived quality of life in younger and older
boys with DMD and unaffected boys. This was accom-
plished by using two self-report outcome measures, the
Children’s Assessment of Participation and Enjoyment
(CAPE) and the Pediatric Quality of Life Inventory
TM 4.0
(PedsQL).
Methods
In our study we collected data from a cohort of boys
participating in a larger natural history study exploring
biomarkers of disease progression in Duchenne muscular
dystrophy. Our study investigated self-report of partici-
pation levels and QoL in boys with DMD compared to
unaffected age-matched boys. Fifty boys with DMD (vali-
dated through medical report using molecular genetic
testing and/or immunohistochemical staining from
muscle biopsy) and their parent(s) volunteered to enroll
in this study. Twenty-five unaffected age-matched boys
were recruited from the general population for compari-
sons in participation and QoL. Unaffected boys were
relatively sedentary, in that they did not participate in
sport specific training more than 2 times per week. All
boys and their parents participated in person at our site.
The boys ranged in age from 5 to 15 years. Three boys
with DMD who were nonambulatory were included in
this study; all others were ambulatory at the time of
testing. The study was approved by the University of
Florida Institutional Review Board (IRB 129-2008). Writ-
ten, informed consent was obtained from the parent(s),
and written assent was obtained from each participant.
Following informed consent, the boys completed two
paper/pencil self-report assessments which focused on
participation in physical, recreational and social activities
and perceived quality of life. Assessments of participation
were completed with the assistance of their parent(s).
Instruments
Participation was measured by the Children’s Assessment
of Participation and Enjoyment (CAPE) [40]. The CAPE
is designed to examine how children and youth participate
in everyday activities. Scores on the CAPE are divided into
five dimensions: 1) Diversity, the number of activities per-
formed overall; 2) Intensity, the frequency of performing
the activity; 3) With Whom the activity is performed; 4)
Where the activity is performed; and 5) how much
Enjoyment the child gets from the activity. Additionally,
activities are divided into the following domains: physical,
recreational, social, skill-based, and self-improvement.
Three activity domains of the CAPE were used in our cal-
culations (physical, recreational and social activities).
Physical activities included such items as playing team
sports, bicycling, and actively using playground equip-
ment. Recreational activities included reading, playing
cards or playing video/computer games. Social activities
included visiting friends, going to the movies, and cooking.
Reliability and validity of the CAPE were established
using data from a longitudinal study involving 427 chil-
dren with physical disabilities [27]. Although validation
studies with the CAPE did not include children with
progressive diseases, such as DMD, other diagnoses
which result in muscle weakness and motor difficulties
were included (i.e., cerebral palsy, amputation, muscular
disorders, neuropathy, orthopaedic conditions, vascular
brain disorders). In addition, the CAPE was designed to
be a direct measure of participation as reflected by the
WHO’s ICF model [27]. The CAPE documents what a
child does in their everyday life, not the child’s compe-
tence or the degree of support required to participate in
the activity [28]. Therefore it was felt the CAPE measure
would adequately capture the boys with DMD involve-
ment in life situations.
Quality of Life (QoL) was assessed through the
Pediatric Quality of Life Inventory
TM 4.0 (PedsQL),
which is designed to measure the core dimensions of health
as delineated by the WHO (physical, emotional, social), as
well as school functioning, and has been determined to be
a thorough and reliable measure of QoL in children
[36,37,41]. Generic quality of life instruments have fre-
quently been used as patient reported outcome measures,
a n dt h e i ru s ee n c o u r a g e dt oe xplore the clinical meaning-
fulness of a change in more traditional clinical measures of
body systems and overall function [26,33]. Generic QoL
measurements provide valuable information for comparing
populations, but may not be sensitive enough to detect
change necessary for a treatment based clinical trial [42].
The PedsQL
TM 4.0 has previously been used to evaluate
patient-perceived well being in boys with DMD and un-
affected controls [43] and to investigate agreement between
boys with DMD and their parents when reporting quality
of life [13,44]. The data for the Generic Core Scales were
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TM 4.0 field test [37]. Generic
Core Scales included children who are healthy, acutely ill,
and chronically ill.
Statistical analysis
All statistical analyses were performed using statistical
software PASW version 18.0 for Windows (PASW Inc.,
Chicago, IL). The Mann–Whitney U-test was used for
group comparisons and the Spearman’s rank correlation
coefficient test was used for non-parametric analysis of
correlations. A p-value of less than or equal to 0.05 was
considered statistically significant. In our aim of explor-
ing the differences in participation in life activities and
perceived QoL between younger and older unaffected
boys and boys with DMD, a p-value of less than or equal
to 0.01 was considered statistically significant due to the
multiple number of analyses performed.
Results
Characteristics of boys with DMD and unaffected age-
matched boys
A comparison of the characteristics of the boys with Du-
chenne muscular dystrophy (DMD) and the unaffected
age-matched boys used in this study is shown in Table 1.
The ages and weights of the boys in both groups were
comparable. However, boys with DMD were shorter in
height and had a higher body mass index (BMI) than un-
affected boys. One possible reason for the decrease in
height and higher BMI may be the fact that all boys in
the DMD group were taking steroids. It is known that
administration of steroids may result in weight gain and
short stature [45]. A comparison of the ability to partici-
pate in life activities and their perceived QoL was made
between these two groups, and the results are presented
below.
Participation and QoL in boys with DMD Vs unaffected
boys
Participation in life activities for each group was assessed
using the Children’s Assessment of Participation and En-
joyment (CAPE), a self-report outcome measure. The
results were divided into four categories (Figure 2). In-
tensity is a measure of the frequency of participation in
chosen activities varying from no participation (score 0)
to once in the last 4 months (score 1) to daily (score 7).
The total number of activities in which an individual par-
ticipates in (Diversity) and intensity scores are used to
compute scores for the three different types of activities:
physical, recreational, and social. The range of activity
scores is from 0 (lowest participation) to 7 (highest par-
ticipation). The results showed lower participation levels
in physical activities in DMD (p<.001), but no signifi-
cant differences between boys with DMD and unaffected
boys in diversity or any of the other categories (intensity,
recreational or social activities).
The perceived QoL for each group was assessed
using the Pediatric Quality of Life Inventory
TM 4.0 ™
(PedsQL), also a self-report outcome measure. These
responses were divided into four subscales: physical,
emotional, social, and school-related. In addition, a
total QoL composite score was also included (Figure 3).
The range of scores is from zero (lowest QoL) to 100
(highest QoL). There were lower scores for boys with
DMD than the unaffected group in physical, social,
school-related, and total composite quality of life
responses. There were no significant differences be-
tween groups in the responses related to emotional fac-
tors. These results demonstrate that, in general, the
perceived QoL is diminished in boys with DMD.
Participation and QoL in younger and older boys
To assess the effects of disease progression, the boys
with DMD and unaffected boys were divided into two
age groups, i.e., less than 10 years and 10 years or older.
The age of 10 years was selected because of the disease
progression and the muscle and functional changes that
reportedly occur for boys with DMD around this age, in-
cluding the ability to rise from the floor, walk up stairs
or ambulate [5,17,19]. All demographics for these two
age groups (age, height, weight, BMI) were statistically
significantly different at p<.001. For boys with DMD,
there were significant differences between the two age
groups in CAPE scores of direct participation in social ac-
tivities (p≤0.01) and a trend toward significance in overall
frequency of participation in all activities (p≤0.05), but no
differences in diversity of activities or participation in
physical or recreational activities. No differences were
observed between these two DMD age groups in self-
report of QoL in any of the subscale scores or the total
composite score of the PedsQL
TM (Table 2). These results
demonstrate that overall, older boys with DMD participate
in a variety of activities, but less often than their younger
peers. More importantly, engagement in social activities
declined significantly for our older boys with DMD.
Interestingly, perceived quality of life did not vary be-
tween the two DMD age groups. For our unaffected
group, no significant differences were found between
t h et w oa g eg r o u p si na n yP e d s Q L
TM subscale scores or
total composite score (Table 2).
Table 1 Characteristics of DMD and unaffected age-
matched subjects
DMD (n=50) Unaffected (n=25)
Age 8.9 (2.4) 8.4 (2.1)
Weight (kg) 32.3 (10.5) 31.1 (10.2)
Height (m) 122.6 (12.5) 142.5 (11.3)**
BMI (kg/m
2) 19.5 (3.4) 16.7 (3.4)*
*p≤.05; **p ≤.01.
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the younger unaffected boys were observed in the CAPE
area of physical participation, as well as the PedsQL
TM
physical subscale and total composite score (all signifi-
cant at p≤0.000). For our older cohort (≥10 years), boys
with DMD scored significantly lower in the physical and
social domains of the CAPE, as well as the PedsQL
TM
physical and social subscales and the total composite
score (Table 2).
Relationship between participation and QoL
As the results above demonstrate, participation in ac-
tivities that were social in nature declined for the older
cohort of boys with DMD; self-report of QoL did not
differ between the two DMD or unaffected age groups.
Correlational analyses showed no significant relation-
ship between overall participation and perceived QoL
in either age group of boys with DMD or unaffected
boys.
***
Figure 2 Baseline CAPE Responses by DMD (n=50) and Unaffected Age-Matched Subjects (n=25). CAPE, Children’s Assessment of
Participation and Enjoyment collection instrument. DMD, Duchenne muscular dystrophy; Range of scores (Intensity 0–7; Physical Activities 0–7;
Recreational Activities 0–7; Social Activities 0–7). Data are presented as means±standard deviations. ***p <0. 001.
*** ***
***
**
Figure 3 Baseline PedsQL Responses by DMD (n=50) and Unaffected Age-Matched Subjects (n=25). DMD, Duchenne muscular
dystrophy; PedsQL
TM, Pediatric Quality of Life collection instrument; Range of scores 0–100. Data are presented as means±standard deviations. *p
<0.05; **p<0.01; ***p<0.001.
Bendixen et al. Health and Quality of Life Outcomes 2012, 10:43 Page 5 of 9
http://www.hqlo.com/content/10/1/43Discussion
In this study we compared participation in life activities
and perceived QoL between boys with DMD and an age-
matched population of unaffected boys. The results
showed that participation in physical activities was sig-
nificantly lower in boys with DMD than unaffected con-
trols, although other participation measures were much
the same as healthy boys. Furthermore, perceived QoL
was markedly diminished in children with DMD relative
to unaffected controls. Another objective of this study
was to compare younger boys to older boys in both the
DMD and unaffected cohorts to explore both within
group and between group differences in participation
and QoL. For within group differences, we found that
the amount of time boys with DMD engage in an activity
(frequency), as well as participation in social activities,
declined for our older cohort but there was no decline in
participation observed for our older unaffected boys. No
differences in perceived QoL were observed between the
younger and older boys with DMD or the unaffected
boys. Significant between age group differences were
observed among the boys with DMD and the unaffected
controls. Comparisons between our younger boys with
DMD and our younger unaffected boys showed lower
scores in diversity of activities they participate in, as well
as participation in physical activities. Quality of life
scores were lower in the physical subscale as well as the
overall total composite score. For our older boys with
DMD, lower scores were reported in both physical and
social participation, as well as quality of life subscales of
physical, social and total composite scores compared to
our older unaffected boys. No differences were observed
in the PedsQL
TM subscales of emotional or school related
QoL for our older boys. Finally, no correlations were
observed between reports of participation and QoL in
these two groups.
Our study is one of the first to explore self-report of
participation in activities in a population of boys with
DMD. The results demonstrated that, overall, the boys
with DMD chose diverse activities in which to participate
and that they were involved in their chosen activities as
frequently as healthy boys. However, the activities of
choice for boys with DMD were less physical in nature
than unaffected boys their age. It certainly comes as no
surprise that children with muscular weakness are less
likely to participate in physical activities, especially as
they age [46,47]. Interestingly, physical activity for
healthy boys has been reported to decline during later
childhood or adolescence stages [48,49], although we did
not observe a decline in our unaffected group of boys. In
contrast, this age-related decline in physical activities for
unaffected boys does not appear to be due to the bodily
demands of the activity [49,50]. Moreover, physical activity
participation is typically high for younger unaffected boys
[50], but was significantly lower in our younger boys with
DMD.
In boys with DMD, participation in social activities, such
as visiting friends, going to parties or going to the movies
was significantly lower after the age of 10 years. This is
often the age when boys with DMD experience a decrease
in motor abilities, such as ambulation [5,46] and may,
therefore, have less opportunity for community-based
social engagement. It’s important to note the connection
between physical abilities and social engagement. Poor
Table 2 Baseline CAPE and PedsQL
TM responses by DMD and unaffected based on age groups: differences within and
between groups
Instruments DMD (n=50) Unaffected (n=25) P value
Between
Groups
<10 years
P value
Between
Groups
≥ 10
years
<10 years
(n=27)
≥ 10
years
(n=23)
<10 years
(n=13)
≥ 10 years
(n= 12)
CAPE Diversity 30.1 (5.2) 27.6 (5.4) 33.3 (7.1) 30.1 (4.2) 0.05 0.19
CAPE Intensity 2.7 (0.6) 2.4 (0.5)* 3.2 (0.8) 2.6 (0.5) 0.18 0.68
CAPE Physical 1.4 (0.7) 1.3 (1.1) 2.9 (0.9) 2.5 (0.9) 0.00 0.01
CAPE Recreational 4.9 (1.0) 4.6 (1.1) 5.2 (0.7) 4.8 (0.7) 0.38 0.42
CAPE Social 3.4 (0.9) 2.4 (0.8)** 3.1 (0.7) 3.0 (0.9) 0.85 0.02
PedsQL Physical 68.1 (16.7) 61.6 (21.2) 87.8 (11.5) 85.3 (12.5) 0.00 0.00
PedsQL
Emotional
63.2 (17.6) 71.8 (19.8) 73.1 (18.8) 73.6 (19.1) 0.13 0.83
PedsQL Social 68.5 (22.9) 65.9 (23.5) 79.9 (21.3) 86.4 (17.9) 0.14 0.03
PedsQL School 64.5 (20.7) 67.7 (18.0) 78.9 (13.9) 81.4 (13.7) 0.18 0.05
PedsQL Total
Composite
66.2 (11.4) 66.7 (16.9) 82.7 (13.1) 81.6 (12.7) 0.00 0.02
DMD, Duchenne muscular dystrophy; CAPE, Children’s Assessment of Participation and Enjoyment collection instrument; CAPE, Range of scores (Diversity 0–55;
Intensity 0–7; Physical Activities 0–7; Recreational Activities 0–7; Social Activities 0–7); PedsQL, Pediatric Quality of Life collection instrument; PedsQL, Range of
scores 0–100. Data are presented as means±standard deviations. *p <.05; **p <.01.
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difficulties, lower peer regard and greater likelihood of
suffering from withdrawal [51]. Actively engaging in
physical activities, such as team sports or playing with
others on the playground, helps children form peer rela-
tionships and experience a sense of self-worth and
belonging to a group [30,40,51,52]. Unfortunately, little
is known about the social engagement of children with
DMD. Although parents more often report prolonging
ambulation as the most important factor in dealing with
DMD [39,53], the resulting emotional challenges of
DMD and the increasing social needs of boys as they age
is also of great concern [39,54].
Our study also used self-report measures to determine
the perceived QoL of the boys with DMD relative to un-
affected controls. The boys with DMD reported lower
physical, social and school-related scores, resulting in
significantly lower total composite QoL scores. However,
there was no effect of the disease in the emotional area of
QoL, even as the boys aged. The differences in these
responses may be due to the types of questions used in the
PedsQL
TM assessment. The questions addressed in the
physical, social, and school-related areas are based on diffi-
culties in actual performance, such as physical activities,
making friends, or missing school due to medical/phys-
ician appointments. On the other hand, the emotional sub-
scale of the PedsQL
TM consists of questions about feelings
of sadness, anger, and fear. These may be emotions that
are evident in most children to some degree and may not
necessarily be exaggerated by the disease. It is interesting
to note that although QoL scores for boys with DMD were
significantly lower than for unaffected boys, these scores
did not notably decrease within the cohort of children with
DMD when the disease has typically progressed. Other
researchers have also reported no changes in QoL related
to disease progression [11,12,43,55]. In a longitudinal
study, Simon and colleagues (2010) used the Life Satisfac-
tion Index for Adolescents, which they determined to be a
more effective instrument for boys with DMD based on its
limited focus on physical abilities. No comparisons were
made with unaffected boys, but the cohort of 95 boys with
DMD did not show a significant decrease and no loss of
QoL was observed among the boys most affected by the
progression of the disease [55]. Abresch et al. [56,57]
determined that physical functioning and level of disability
alone did not alter overall QoL, a finding that was also
reported by Kohler et al. [43] using the Short-Form 36 of
the medical outcome questionnaire. Finally, based on
PedsQL
TM scores established and validated in a variety of
patient populations [37,58], the overall scores for our co-
hort of boys with DMD were lower than scores from chil-
dren with other major chronic health issues.
In our study, we did not find a relationship between
CAPE participation scores and PedsQL
TM quality of life
scores for unaffected boys or boys with DMD, although
relationships between QoL and specific clinical measures
that are typically assessed in boys with DMD have been
observed. Bray et al. [13] found relationships between
age, steroid use, physical functioning and QoL in DMD.
McDonald et al. [44] utilized parent-proxy report and
found direct relationships between the physical domains
of QoL, age, and such clinical assessments as supine to
stand, walk/run 10 meters and walk up 4 stairs. Findings
from other studies in DMD support the thought that
meaningful and developmentally important life activities,
such as playing with and actively engaging with friends,
may be related to QoL [11,59]. It is difficult to explain
these varying results and why we did not find a correlation
between participation and QoL. Although our sample size
was small, it would also appear that QoL is complex and
more global in nature than the straightforward and explicit
report of actual participation. As Colver theorized, QoL
cannot be measured directly, but only captured through a
variety of questions that seek to place value on a particular
variable [60]. Therefore, QoL is a concept and is subjective
[55], while participation is a real life experience and is ob-
jective [61-63]. Finally, our results may differ from some
studies because we chose to use child report in lieu of par-
ent proxy report to obtain a full understanding of the chil-
dren’s perception of their QoL. Literature in this area
shows that parents and children often differ in their agree-
ment of the child’s QoL [13,44,64], but the larger issue
appears to be whether a child is capable of self-report
[65,66]. We took the stance, as others have, that children
can provide valuable information about their health and
that quality of life is subjective and therefore should be a
person’s individual view [33,61,65,66].
Limitations
We acknowledge there are a few limitations to our study.
Although our population of boys with DMD is rare, our
sample size may be considered relatively small, especially
when broken into age groups. Moreover, as this was not a
longitudinal study, comparing different age groups may not
be giving us information about changes as the disease pro-
gresses. Lastly, although the PedsQL
TM is a thoroughly
developed generic measure that is brief, easy to understand,
and captures information relevant to both children with a
disease/illness and unaffected children, we acknowledge
that the PedsQL
TM domains are limited, are not designed
to assess a full range of functioning and are not specific to
children with a neuromuscular disorder.
Conclusions
Although a progressive disease, such as DMD, influences
the physical ability to participate in many activities, it’s
important to acknowledge that restrictions in
Bendixen et al. Health and Quality of Life Outcomes 2012, 10:43 Page 7 of 9
http://www.hqlo.com/content/10/1/43participation should not inevitably arise from this or any
childhood disease. Optimum management of DMD
requires a multidisciplinary approach that focuses on an-
ticipatory and preventive measures as well as active
interventions to address the primary and secondary com-
plications resulting from the disorder [6]. Such a multi-
disciplinary approach would benefit from using a
framework to conceptualize the process of living with a
progressive disease. The ICF-CY [25] provides a concep-
tual framework and specific terminology that facilitates in-
vestigation of the consequences of chronic illness and
impairment in children and youth. The ICF model provides
areas of intervention that can enhance the participation of
children whose functional well-being is at risk. Interven-
tions that focus on multiple aspects of the child and ad-
dress participation afford children the opportunity to
continue to engage in age and developmentally appropriate
activities, and ultimately may serve to promote overall
health [61,62]. Results from our study underscore the need
to further evaluate activities that children elect to partici-
pate in to obtain an accurate account of a child’sl e v e lo f
participation and how participation changes throughout
the course of a disease. Additionally, exploring how par-
ticipation may relate to specific clinical tests may give us
a better understanding of areas of intervention.
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